Jasmeet Kaur
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Biotechnology top 10%
- Enzyme Production and Characterization
Papers in
- Co-authors
- Sankar Nath Sanyal (12 shared papers)Harvinder Singh Saini (1 shared paper)B. Kumar (1 shared paper)Bhupinder Singh Chadha (1 shared paper)Shalmoli Bhattacharyya (1 shared paper)Sonia Shalini (1 shared paper)M. P. Bansal (1 shared paper)Manpreet Kaur Saini (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (2 papers)European Journal of Cancer Prevention (2 papers)Therapeutic Advances in Medical Oncology (2 papers)Nuclear Medicine and Biology (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Jasmeet Kaur
66 papers receiving 580 citations
Peers
Comparison fields: 5 of 110
- Pharmacology 118
- Biotechnology 63
- Transplantation 15
- Cancer Research 59
- Microbiology 3
Countries citing papers authored by Jasmeet Kaur
This map shows the geographic impact of Jasmeet Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmeet Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmeet Kaur more than expected).
Fields of papers citing papers by Jasmeet Kaur
This network shows the impact of papers produced by Jasmeet Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmeet Kaur. The network helps show where Jasmeet Kaur may publish in the future.
Co-authors
The 25 scholars most cited alongside Jasmeet Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 79 | |
| 2 | 2010 | 65 | |
| 3 | 2011 | 42 | |
| 4 | 2010 | 30 | |
| 5 | 2009 | 24 | |
| 6 | 2021 | 23 | |
| 7 | 2021 | 22 | |
| 8 | 2010 | 18 | |
| 9 | 2010 | 18 | |
| 10 | 2017 | 17 | |
| 11 | 2021 | 17 | |
| 12 | 2014 | 16 | |
| 13 | Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model. | 2010 | 15 |
| 14 | 2008 | 15 | |
| 15 | 2010 | 12 | |
| 16 | Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis. | 2010 | 11 |
| 17 | 2011 | 11 | |
| 18 | 2016 | 10 | |
| 19 | 2012 | 9 | |
| 20 | 2021 | 9 |
About Jasmeet Kaur
Jasmeet Kaur is a scholar working on Oncology, Surgery, Pharmacology, Molecular Biology and Epidemiology, having authored 75 papers that have together received 601 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Pancreatic and Hepatic Oncology Research (5 papers), Estrogen and related hormone effects (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), COVID-19 Clinical Research Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Pharmacology (118 citations), Biotechnology (63 citations), Transplantation (15 citations), Cancer Research (59 citations) and Microbiology (3 citations). Jasmeet Kaur has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Sankar Nath Sanyal, Harvinder Singh Saini, B. Kumar, Bhupinder Singh Chadha, Shalmoli Bhattacharyya, Sonia Shalini, M. P. Bansal, Manpreet Kaur Saini, Vivek Vaish and Pooja Ghatalia. Their work appears in journals such as Journal of Clinical Oncology, Blood, European Journal of Cancer Prevention, Therapeutic Advances in Medical Oncology and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.